Mycobacteriology – Specimen Packaging & Shipping: Introduction, Procedure, Application, Precaution, and Keynotes

Introduction

Mycobacteriology specimen packaging and shipping involve the standardized containment and transport of biological materials suspected of containing Mycobacterium species. Because organisms such as Mycobacterium tuberculosis are highly infectious airborne pathogens (Risk Group 3), their transport is strictly governed by the U.S. Department of Transportation (DOT) and the International Air Transport Association (IATA) Dangerous Goods Regulations.  Proper execution preserves sample viability, prevents laboratory rejection, and eliminates environmental exposure hazards for couriers and handlers.

Classification of Materials

Biological substances are divided into two regulatory categories that dictate their specific packaging and shipping workflows:

Classification	Description	Proper Shipping Name & UN Number
Category A	High-risk infectious substances capable of causing permanent disability or life-threatening disease upon human exposure.	UN 2814 (Infectious substance, affecting humans).
Category B	Lower-risk diagnostic specimens that do not meet Category A criteria.	UN 3373 (Biological Substance, Category B).

• Mycobacterial Cultures: Propagated isolates or cultures of M. tuberculosis are always classified as Category A.
• Patient Specimens: Raw clinical samples (e.g., sputum, bronchial washes) from patients suspected of having tuberculosis are classified as Category B.
• Non-Tuberculosis Mycobacteria (NTM): Cultures and specimens of other Mycobacterium species (e.g., M. avium complex) are classified as Category B.

Procedure: The Triple Packaging System

Both Category A and Category B materials must be shipped using a mandatory Triple Packaging System. This configuration features three distinct containment barriers designed to withstand transit vibrations, pressure differentials, and physical impacts.

[ Primary Receptacle ] → [ Secondary Packaging ] → [ Rigid Outer Packaging ]→

  (Leak-proof Tube) → (Absorbent + Canister)→(Certified Box + UN Label)

1. Primary Receptacle

• Place the clinical specimen or isolate into a leak-proof, screw-capped container.
• For primary sputum specimens, use standard 50 mL conical centrifuge tubes.
• Ensure the cap is tightly closed.
• Seal the cap perimeter with a single layer of parafilm or adhesive tape to prevent loosening from pressure drops.
• Label the tube clearly with at least two unique patient identifiers.

2. Secondary Packaging

• Wrap the primary container securely in cushioning bubble wrap.
• Surround the primary receptacle with sufficient absorbent material (e.g., cotton wool or cellulose pads) to absorb the entire liquid volume in the event of breakage.
• Place the wrapped tube into a secondary leak-proof container, such as a 95 kPa pressure-certified canister or a sealed biohazard Ziploc bag.
• If shipping multiple primary tubes in one secondary package, wrap each tube individually to prevent glass-to-glass or plastic-to-plastic contact.

3. Outer Packaging

• Place the sealed secondary packaging into a rigid outer shipping container (e.g., a heavy-duty cardboard box or an insulated cooler for cold transport).
• For Category A shipments, this outer box must display a UN specification marking proving it has passed performance testing.
• Insert the required Case Investigation Form (CIF) or laboratory requisition paperwork into an external pouch on the outside of the secondary packaging.
• Note: Never place the paperwork inside the secondary container with the specimen to avoid biological contamination.

Application

Standardized mycobacteriology packaging applies to several clinical scenarios:

• Diagnostic Sputum Collection: Transporting morning-collected, deep-cough respiratory specimens to reference centers for acid-fast bacilli (AFB) smear microscopy and automated Nucleic Acid Amplification Techniques (NAAT).
• Reference Laboratory Referral: Shipping positive mycobacterial liquid or solid cultures to state or national public health entities for definitive identification and Drug Susceptibility Testing (DST).
• Extrapulmonary TB Surveillance: Handling and routing specialized samples like gastric washes, pleural fluids, and sterile tissue biopsies under strict cold-chain infrastructure.

Precautions

• Temperature Management: Maintain raw, unprocessed respiratory specimens under refrigeration at 2–8°C if delivery is delayed beyond 24 hours. Never freeze clinical samples because freezing destroys cell viability.
• Gastric Wash Neutralization: Acidic gastric washings kill mycobacteria rapidly. Neutralize these samples by adding 100 mg of sodium carbonate within one hour of collection if immediate transport is unavailable.
• No Petri Dishes: Do not ship cultures or isolates on open agar Petri plates. Isolates must always be transferred onto solid media slants in screw-capped tubes or into liquid culture bottles.
• Pressure Competency: Ensure that either the primary receptacle or the secondary packaging is officially rated to withstand an internal pressure differential of 95 kPa without leakage during air transport.

Keynotes

• Mandatory Training: Personnel packing or documenting Category A or B dangerous goods must hold a valid, employer-verified shipping certification. This certification requires retraining every 2 years for IATA (air) and every 3 years for DOT (ground).
• Outer Label Checklist: The outside of every shipping box must feature the sender’s and receiver’s address, a 24-hour emergency contact number, a diamond-shaped UN 3373 label (for Category B) or UN 2814 label (for Category A), and proper package orientation arrows.
• Volume Limits: For air transport via passenger aircraft, the maximum allowable volume of a Category A substance per package is limited to 50 mL or 50 g.
• Notification of Shipment: Always contact the receiving reference facility or courier service before shipping high-consequence dangerous goods to ensure alignment on weekend intake capabilities and delivery timelines.

Further Readings

1. https://ehs.georgetown.edu/biological/iata-dot/
2. https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/2022-06/Transporting-Infectious-Substances-Safely.pdf
3. https://www.mass.gov/doc/division-62-infectious-substance-shipping-guide-classification-packing-marking-and-labeling/download
4. https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/2022-06/Transporting-Infectious-Substances-Safely.pdf
5. https://www.airseadg.com/packaging/infectious-substances-category-a-category-b-packaging-explained/
6. https://www.airseadg.com/packaging/infectious-substances-category-a-category-b-packaging-explained/
7. https://iris.who.int/server/api/core/bitstreams/bebbc361-e2f7-40d0-9e8f-6e4660869b64/content
8. https://www.dshs.texas.gov/laboratory-services/programs-laboratories/microbiology-unit/mycobacteriology-laboratory/submitting-mycobacterium-specimens
9. https://www.azdhs.gov/documents/preparedness/state-laboratory/category-a-and-b-shipping-examples.pdf
10. https://cdn.iuhealth.org/resources/IUH-Microbiology-Specimen-Collection-Guide-91025.pdf
11. https://cdn.iuhealth.org/resources/IUH-Microbiology-Specimen-Collection-Guide-91025.pdf
12. https://www.simpios.eu/wp-content/uploads/2024/04/b40_6_1_en_Micobatteri140522.pdf
13. https://cdn.who.int/media/docs/default-source/immunization/vpd_surveillance/lab_networks/measles_rubella/manual/annex-3.1-packaging-of-specimens-and-virus-isolates.pdf?sfvrsn=1741eade_9
14. https://netec.org/2023/01/18/lab-samples-and-suspect-cases/
15. https://www.biosafety.be/sites/default/files/mtub_final_dl.pdf